Home
About
Contact
Home
Home
Finance
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Trending mini
00:10
from Yahoo Finance https://ift.tt/zyGqY1C
Post a Comment
0 Comments
Social Plugin
Popular Posts
Epic says it "will start developing the Epic Games Store on iOS soon thanks to the new Digital Markets Act", after Apple approved its developer account (William Gallagher/AppleInsider)
01:32
Arm transitions to a comprehensive 64-bit platform with new mobile CPU core designs Cortex-X4, Cortex-A720, and Cortex-A520, built on its Armv9.2 architecture (Gavin Bonshor/AnandTech)
00:32
A deep dive into the debate about Claude Mythos Preview, the model's capabilities, attempts to refute Anthropic's claims, and what it means for the future of AI (Zvi Mowshowitz/Don't Worry About the Vase)
03:32
Ads by Eonads
0 Comments